We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

In Vitro Activity of Piperacillin and Other Microbials on 491 Bacterial Isolates

D. S. Reeves, MB
Arch Intern Med. 1982;142(11):2023-2032. doi:10.1001/archinte.1982.00340240045009.
Text Size: A A A
Published online


• We tested the activity of piperacillin against 491 bacterial local clinical isolates in comparison with ampicillin, mezlocillin, cefazolin, cefoperazone, cefotaxime, ceftazidime, moxalactam, and gentamicin, using an agar dilution technique and inocula of 106 and 104 colony forming units. The results confirmed the broad-spectrum activity of piperacillin against a wide range of bacterial pathogens. The activity against Pseudomonas aeruginosa was encouraging, and it was one of the most active agents tested against that species. Its lack of stability for certain types of β-lactamases was manifested by large differences in the minimal inhibitory concentration (MIC) activity between inocula of 106 and 104, and by the high MIC to inhibit 90% of strain of certain species compared with the MIC to inhibit 50% of strain. The activity of piperacillin suggests its clinical evaluation for use in combination with other agents in serious sepsis, in situations where β-lactamase—producing strains are rare, and in antipseudomonal therapy.

(Arch Intern Med 1982;142:2023-2032)


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.